Bioptik Technology, Inc. Statistics
Bioptik Technology, Inc. (4161) Stock Statistics & Valuation Metrics
Total Valuation
Bioptik Technology, Inc. has a market cap or net worth of TWD 1.22B. The enterprise value is TWD 1.40B.
- Market Cap
- TWD 1.22B
- Enterprise Value
- TWD 1.40B
Share Statistics
Bioptik Technology, Inc. has 59,798,203 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 59,798,203
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Bioptik Technology, Inc.’s return on equity (ROE) is 0.07 and return on invested capital (ROIC) is 3.78%.
- Return on Equity (ROE)
- 0.07
- Return on Assets (ROA)
- 0.05
- Return on Invested Capital (ROIC)
- 3.78%
- Return on Capital Employed (ROCE)
- 0.06
- Revenue Per Employee
- 10.46M
- Profits Per Employee
- 889.90K
- Employee Count
- 80
- Asset Turnover
- 0.53
- Inventory Turnover
- 2.92
Valuation Ratios
The current PE Ratio of Bioptik Technology, Inc. is 11.13. Bioptik Technology, Inc.’s PEG ratio is 0.25.
- PE Ratio
- 11.13
- PS Ratio
- 1.36
- PB Ratio
- 1.20
- Price to FCF
- 37.62
- Price to Operating Cash Flow
- 23.30
- PEG Ratio
- 0.25
Income Statement
In the last 12 months, Bioptik Technology, Inc. had revenue of 837.19M and earned 71.19M in profits. Earnings per share was 1.23.
- Revenue
- 837.19M
- Gross Profit
- 243.51M
- Operating Income
- 66.73M
- Pretax Income
- 85.32M
- Net Income
- 71.19M
- EBITDA
- 99.50M
- Earnings Per Share (EPS)
- 1.23
Cash Flow
In the last 12 months, operating cash flow was 51.05M and capital expenditures -18.15M, giving a free cash flow of 32.90M billion.
- Operating Cash Flow
- 51.05M
- Free Cash Flow
- 32.90M
- Free Cash Flow per Share
- 0.57
Dividends & Yields
Bioptik Technology, Inc. pays an annual dividend of ―, resulting in a dividend yield of 3.37%
- Dividend Per Share
- ―
- Dividend Yield
- 3.37%
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 2.66%
- Earnings Yield
- 9.11%
Stock Price Statistics
- Beta
- 0.19
- 52-Week Price Change
- -20.31%
- 50-Day Moving Average
- 21.77
- 200-Day Moving Average
- 22.94
- Relative Strength Index (RSI)
- 36.81
- Average Volume (3m)
- 24.33K
Important Dates
Bioptik Technology, Inc. upcoming earnings date is Mar 05, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Nov 06, 2026
- Next Earnings Date
- Mar 05, 2027
- Ex-Dividend Date
- ―
Financial Position
Bioptik Technology, Inc. as a current ratio of 1.93, with Debt / Equity ratio of 48.53%
- Current Ratio
- 1.93
- Quick Ratio
- 1.51
- Debt to Market Cap
- 0.33
- Net Debt to EBITDA
- 0.72
- Interest Coverage Ratio
- 8.77
Taxes
In the past 12 months, Bioptik Technology, Inc. has paid 15.48M in taxes.
- Income Tax
- 15.48M
- Effective Tax Rate
- 0.18
Enterprise Valuation
Bioptik Technology, Inc. EV to EBITDA ratio is 10.85, with an EV/FCF ratio of 39.28.
- EV to Sales
- 1.42
- EV to EBITDA
- 10.85
- EV to Free Cash Flow
- 39.28
- EV to Operating Cash Flow
- 25.32
Balance Sheet
Bioptik Technology, Inc. has TWD 442.58M in cash and marketable securities with TWD 467.82M in debt, giving a net cash position of -TWD 25.23M billion.
- Cash & Marketable Securities
- TWD 442.58M
- Total Debt
- TWD 467.82M
- Net Cash
- -TWD 25.23M
- Net Cash Per Share
- -TWD 0.42
- Tangible Book Value Per Share
- TWD 17.23
Margins
Gross margin is 28.16%, with operating margin of 7.77%, and net profit margin of 11.84%.
- Gross Margin
- 28.16%
- Operating Margin
- 7.77%
- Pretax Margin
- 13.83%
- Net Profit Margin
- 11.84%
- EBITDA Margin
- 13.04%
- EBIT Margin
- 10.37%
Analyst Forecast
The average price target for Bioptik Technology, Inc. is ―, which is 11.43% higher than the current price. The consensus rating is ―
- Price Target
- ―
- Price Target Upside
- ―
- Analyst Consensus
- ―
- Analyst Count
- ―
- Revenue Growth Forecast
- 10.76%
- EPS Growth Forecast
- 64.25%
